Medications

Chip-in-a-pill may be approved in 2012

(PhysOrg.com) -- Giant Swiss pharmaceutical company Novartis AG, based in Basel, is developing a pill containing an embedded microchip, which it hopes to submit for regulatory approval in Europe within 18 months. The chip ...

Medical research

Biotech startup uses nanoparticles to induce immune tolerance

More than 100 approved drugs in the U.S. warn of immune-related side effects on their labels. Countless others never make it onto shelves because of unwanted immune responses that can harm patients and limit the effectiveness ...

Surgery

Researchers discover indicator of lung transplant rejection

Research by scientists at Dignity Health St. Joseph's Hospital and Medical Center's Norton Thoracic Institute was published in the July 12, 2017 issue of Science Translational Medicine titled "Zbtb7a induction in alveolar ...

Immunology

Experts uncover first molecular events of organ rejection

Researchers at the University of Pittsburgh School of Medicine and the University of Toronto have uncovered the first molecular steps that lead to immune system activation and eventual rejection of a transplanted organ. The ...

Psychology & Psychiatry

Psilocybin reduces psychological pain after social exclusion

Social problems are key characteristics in psychiatric disorders and are insufficiently targeted by current treatment approaches. By applying brain imaging methods, researchers at the University of Zurich now show that a ...

page 1 from 23